Also trades as: PAR.AX (ASX) · $vol 0M
PBIGF Earnings
Paradigm Biopharmaceuticals Limited
1W: -86.8%
1M: -98.9%
3M: -99.1%
YTD: -99.4%
1Y: -99.2%
3Y: -99.8%
5Y: -99.9%
$0.00
-0.00 (-17.65%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Last Earnings
2025-02-26
EPS
A$-0.01 (US$-0.00)
▼ Miss +0.0%
Revenue
A$5K ($4K)
▲ Beat +0.0%
Next Earnings
2026-08-28
1 USD = 1.44 AUD
Estimate vs Actual
Earnings Surprise History
0/8
EPS Beats
0/8
Revenue Beats
0%
EPS Beat Rate
0%
Rev Beat Rate
Wall Street Forward Estimates
Quarterly
Annual
Estimate Revisions
Recent Revisions
| Date | Period | Fiscal Date | EPS Old | EPS New | Change | Rev Old | Rev New |
|---|---|---|---|---|---|---|---|
| 2026-10-02 | annual | 2027-06-30 | A$-0.08 | A$-0.08 | — | A$2,978,165 | A$2,978,165 |
| 2026-10-02 | annual | 2028-06-30 | A$0.18 | A$0.18 | — | A$324,548,274 | A$322,717,503 |
| 2026-10-01 | annual | 2027-06-30 | A$-0.08 | A$-0.08 | — | A$2,978,165 | A$2,978,165 |
| 2026-10-01 | annual | 2028-06-30 | A$0.18 | A$0.18 | — | A$326,053,781 | A$324,548,274 |
| 2026-09-30 | annual | 2027-06-30 | A$-0.08 | A$-0.08 | — | A$2,978,165 | A$2,978,165 |
| 2026-09-30 | annual | 2028-06-30 | A$0.18 | A$0.18 | — | A$326,332,579 | A$326,053,781 |
| 2026-09-29 | annual | 2027-06-30 | A$-0.08 | A$-0.08 | — | A$2,978,165 | A$2,978,165 |
| 2026-09-29 | annual | 2028-06-30 | A$0.18 | A$0.18 | — | A$325,756,397 | A$326,332,579 |
| 2026-09-28 | annual | 2027-06-30 | A$-0.08 | A$-0.08 | — | A$2,978,165 | A$2,978,165 |
| 2026-09-28 | annual | 2028-06-30 | A$0.18 | A$0.18 | — | A$326,913,407 | A$325,756,397 |
| 2026-09-25 | annual | 2027-06-30 | A$-0.09 | A$-0.08 | ▲ 0.01 | A$2,978,165 | A$2,978,165 |
| 2026-09-25 | annual | 2028-06-30 | A$0.19 | A$0.18 | ▼ 0.01 | A$330,695,761 | A$326,913,407 |
| 2026-09-24 | annual | 2028-06-30 | A$0.19 | A$0.19 | — | A$330,830,513 | A$330,695,761 |
| 2026-09-24 | annual | 2027-06-30 | A$-0.09 | A$-0.09 | — | A$2,978,165 | A$2,978,165 |
| 2026-09-23 | annual | 2027-06-30 | A$-0.09 | A$-0.09 | — | A$2,978,165 | A$2,978,165 |
Earnings Call Transcripts
No transcripts available.